Possible Interaction between Phenobarbital, Carbamazepine and Itraconazole
Authors:
- 1 October 1993
- journal article
- case report
- Published by Springer Nature in Drug Safety
- Vol. 9 (4) , 309-311
Abstract
We report a case of a possible interaction between itraconazole, phenobarbital and carbamazepine. The first plasma itraconazole concentration, measured when the patient had been taking phenobarbital for 2 months, was very low. The second measurement, 2 months after withdrawing phenobarbital, was higher but below the therapeutic range. However, carbamazepine, a well known enzyme inducer, had been initiated 15 days before. 20 days after carbamazepine was withdrawn, the itraconazole concentration 4 hours after administration was near the lower end of the therapeutic range. The mechanism of this possible interaction is probably the same for phenobarbital and carbamazepine, involving hepatic microsomal enzyme system induction.Keywords
This publication has 11 references indexed in Scilit:
- Systemically Administered Antifungal AgentsDrugs, 1992
- Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.1991
- Itraconazole and anti-tuberculosis drugsThe Lancet, 1990
- Potentiation of action of warfarin by itraconazole.BMJ, 1990
- Cyclosporine and Itraconazole Interaction in Heart and Lung Transplant RecipientsAnnals of Internal Medicine, 1990
- ItraconazoleDrugs, 1989
- An evaluation of itraconazole in the management of onychomycosisBritish Journal of Dermatology, 1988
- Early Experience with Itraconazole in Vitro and in Patients: Pharmacokinetic Studies and Clinical ResultsClinical Infectious Diseases, 1987
- Effects of carbamazepine on valproic acid kinetics in normal subjectsClinical Pharmacology & Therapeutics, 1979
- Carbamazepine‐induced acceleration of diphenylhydantoin and warfarin metabolism in manClinical Pharmacology & Therapeutics, 1971